How to use the speech recognition tool?

NCT03780257

STELLAR

Study to Evaluate Safety and Tolerability of QR-421a in Subjects With Retinitis Pigmentosa Due to Mutations in Exon 13 of the USH2A Gene (Stellar).

Type: Interventional



Status of the trial: Active, Recruiting

Orphan Drug Recognition: No

Inclusion

  • Opening Date: 2019-03-27
  • Closing Date: 2022-06-01

Criteria

More information

Children: No

Adults: Yes

Funder Type: industry

HCP: Other investigators


Within ERN-EYE members

Principal investigators




Other investigators

Workgroups

  • Retinal Rare Eye Diseases (WG1)

Subscribe to our mailing list

* indicates required

This ERN is supported by: